Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) Stock Rating Reaffirmed as Buy by TD Cowen

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS)‘s stock had its “buy” rating reaffirmed by research analysts at TD Cowen in a research note issued to investors on Tuesday, Benzinga reports. They presently have a $15.00 price target on the stock. TD Cowen‘s target price points to a potential upside of 81.25% from the stock’s current price.

Other equities analysts have also issued reports about the stock. Mizuho reduced their price target on shares of Senseonics Holdings, Inc. Common Stock from $20.00 to $18.00 and set an “outperform” rating on the stock in a research report on Wednesday, July 15th. Weiss Ratings downgraded Senseonics Holdings, Inc. Common Stock from a “sell (d-)” rating to a “sell (e+)” rating in a research note on Thursday. Barclays assumed coverage on Senseonics Holdings, Inc. Common Stock in a research note on Wednesday, October 7th. They issued an “equal weight” rating and a $10.00 target price for the company. Finally, Wall Street Zen raised Senseonics Holdings, Inc. Common Stock from a “strong sell” rating to a “sell” rating in a research report on Saturday, August 8th. Three equities research analysts have rated the stock with a Buy rating, two have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Senseonics Holdings, Inc. Common Stock currently has an average rating of “Hold” and a consensus price target of $13.00.

Senseonics Holdings, Inc. Common Stock Stock Performance

SENS stock traded up $0.80 during trading on Tuesday, reaching $8.28. 439,038 shares of the company’s stock were exchanged, compared to its average volume of 662,687. The company’s fifty day moving average price is $9.15 and its 200-day moving average price is $7.16. The company has a quick ratio of 6.40, a current ratio of 6.74 and a debt-to-equity ratio of 0.62. The firm has a market cap of $345.94 million, a PE ratio of -3.72 and a beta of 1.02. Senseonics Holdings, Inc. Common Stock has a 1-year low of $4.79 and a 1-year high of $10.64.

Senseonics Holdings, Inc. Common Stock (NASDAQ:SENS) last posted its quarterly earnings results on Thursday, August 6th. The company reported ($0.63) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.55) by ($0.08). Senseonics Holdings, Inc. Common Stock had a negative net margin of 225.09% and a negative return on equity of 165.80%. The company had revenue of $14.48 million during the quarter. On average, research analysts expect that Senseonics Holdings, Inc. Common Stock will post -2.31 EPS for the current fiscal year.

Insider Buying and Selling

In related news, Director Douglas Roeder acquired 13,953 shares of the firm’s stock in a transaction that occurred on Wednesday, August 19th. The shares were bought at an average cost of $8.98 per share, for a total transaction of $125,297.94. Following the completion of the transaction, the director owned 171,191 shares in the company, valued at approximately $1,537,295.18. This trade represents a 8.87% increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 4.70% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Senseonics Holdings, Inc. Common Stock

Several hedge funds have recently made changes to their positions in the business. BlackRock Inc. purchased a new position in shares of Senseonics Holdings, Inc. Common Stock during the second quarter valued at about $15,867,000. Masters Capital Management LLC increased its stake in Senseonics Holdings, Inc. Common Stock by 100.0% during the 1st quarter. Masters Capital Management LLC now owns 500,000 shares of the company’s stock valued at $3,330,000 after purchasing an additional 250,002 shares in the last quarter. Bank of America Corp DE purchased a new position in shares of Senseonics Holdings, Inc. Common Stock in the second quarter worth about $2,241,000. Readystate Asset Management LP purchased a new stake in Senseonics Holdings, Inc. Common Stock in the 2nd quarter worth approximately $574,000. Finally, Penn Capital Management Company LLC acquired a new position in shares of Senseonics Holdings, Inc. Common Stock in the second quarter worth about $535,000. 12.36% of the stock is owned by hedge funds and other institutional investors.

Senseonics Holdings, Inc. Common Stock Company Profile

Senseonics Holdings, Inc is a medical technology company focused on developing and commercializing long-term, implantable continuous glucose monitoring (CGM) systems for people with diabetes. Its CGM technology is designed to measure glucose levels continuously through a small sensor inserted under the skin, with readings transmitted to an external smart transmitter and mobile application.

The company’s primary product is the Eversense CGM system. Unlike many conventional CGM systems that use an externally worn sensor, Eversense uses an implantable sensor and a removable, rechargeable transmitter worn over the sensor site.